Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
32m agoIllinois American Water Celebrates Earth Day with a Focus on Sustainable Operations & Water Source Protection
58m agoRegistered Agents Inc Acquires Additional Stake in LegalZoom, Citing Low Cost & Growth Potential
59m agoNuvation Bio Announces IBTROZI® (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026
1h agoGulfport Energy Schedules First Quarter 2026 Earnings Release and Conference Call
1h agoRevolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting

Clinuvel Pharmaceuticals Ltd

About

Clinuvel Pharmaceuticals Ltd (AU:CUV) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 27 2026
CLINUVEL's global programs showcased at AAD
Mar 20 2026
Chair Letter to Shareholders
Feb 26 2026
Half Year Results Presentation
Feb 26 2026
CLINUVEL Record Revenues, Advances Strategic Expansion
Feb 26 2026
Appendix 4D and Half Year Report

Financials

Revenue
A$96.3 M
Market Cap
A$452.81 M
P/E Ratio
14.09
EPS
0.64
Dividend Yield
0.51%

Community Chat

Ask AI

6ix6ixAIEvents